SHIFT AI Newsroom · GLOBAL
Semaglutide Being Investigated for Diabetic Eye Disease in Type 2 Diabetes
A research study is comparing semaglutide to placebo in affecting diabetic eye disease in people with type 2 diabetes
A research study has been registered to investigate the effects of semaglutide on diabetic eye disease in people with type 2 diabetes. The study, comparing semaglutide to placebo, aims to provide insight into the management of diabetic eye disease.
What this means in the UK
The study's findings could potentially impact the management of diabetic eye disease in people with type 2 diabetes in the UK
Known facts
- Semaglutide is being compared to placebo in a research study for diabetic eye disease in people with type 2 diabetes